PROCEPT BioRobotics Corp

For the period ended Mar 31, 2026. Filed Apr 30, 2026.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2026 · Filed Apr 30, 2026

PRCT$23.05+3.0%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Item 1. Condensed Consolidated Financial Statements (unaudited)

CONDENSED CONSOLIDATED BALANCE SHEETS

(in thousands, except per share data)

	March 31,	December 31,
	2026	2025
Assets
Current assets:
Cash and cash equivalents	$245,641	$286,503
Accounts receivable, net	96,388	83,533
Inventory	77,536	70,694
Prepaid expenses and other current assets	8,469	9,648
Total current assets	428,034	450,378
Restricted cash, non-current	3,038	3,038
Property and equipment, net	31,739	30,399
Operating lease right-of-use assets, net	17,162	17,538
Intangible assets, net	640	709
Other assets	6,449	6,019
Total assets	$487,062	$508,081
Liabilities and Stockholders' Equity
Current liabilities:
Accounts payable	$18,851	$17,285
Accrued compensation	18,476	23,175
Deferred revenue	13,702	13,048
Operating lease, current	2,358	2,214
Other current liabilities	10,249	10,073
Total current liabilities	63,636	65,795
Long-term debt	51,664	51,615
Operating lease, non-current	23,974	24,654
Other non-current liabilities	121	147
Total liabilities	139,395	142,211
Commitments and contingencies (see Note 11)
Stockholders’ equity:
Preferred stock, $0.00001 par value;
Issued and outstanding shares: none at March 31, 2026 and December 31, 2025	—	—
Common stock, $0.00001 par value;
Issued and outstanding shares: 56,897 and 56,323 at March 31, 2026 and December 31, 2025, respectively	—	—
Additional paid-in capital	1,020,881	1,007,390
Accumulated other comprehensive gain (loss)	(19)	37
Accumulated deficit	(673,195)	(641,557)
Total stockholders’ equity	347,667	365,870
Total liabilities and stockholders’ equity	$487,062	$508,081

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.